Detalhe da pesquisa
1.
Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission.
Blood
; 143(19): 1931-1936, 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38364112
2.
Molecular, clinical and therapeutic determinants of outcome in NPM1 mutated AML.
Blood
; 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38691678
3.
Impact of body mass index on outcome and treatment-related toxicity in young adults with acute lymphoblastic leukemia.
Acta Oncol
; 62(12): 1723-1731, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37725524
4.
Neoehrlichia mikurensis in Danish immunocompromised patients: a retrospective cohort study.
Ann Clin Microbiol Antimicrob
; 22(1): 20, 2023 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36941613
5.
A survey on thromboprophylaxis and coagulation assessment in children and young adults with acute lymphoblastic leukaemia (ALL) in the Nordic and Baltic countries: Different practices of assessment and management.
Br J Haematol
; 199(1): 117-121, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35922061
6.
Effects of germline DHFR and FPGS variants on methotrexate metabolism and relapse of leukemia.
Blood
; 136(10): 1161-1168, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32391884
7.
Molecular MRD status and outcome after transplantation in NPM1-mutated AML.
Blood
; 135(9): 680-688, 2020 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31932839
8.
Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0-45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol.
BMC Cancer
; 22(1): 483, 2022 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35501736
9.
Disseminated fusariosis with cerebral involvement in a patient with acute myeloid leukemia: Successful outcome with intrathecal -and systemic antifungal treatment.
J Infect Chemother
; 28(9): 1324-1328, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641412
10.
Increments in DNA-thioguanine level during thiopurine-enhanced maintenance therapy of acute lymphoblastic leukemia.
Haematologica
; 106(11): 2824-2833, 2021 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34047177
11.
SARS-CoV-2 infection among patients with haematological disorders: Severity and one-month outcome in 66 Danish patients in a nationwide cohort study.
Eur J Haematol
; 106(1): 72-81, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32939853
12.
Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria.
Haematologica
; 109(3): 929-935, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37534517
13.
Impact of Allogeneic Stem Cell Transplantation in First Complete Remission in Acute Myeloid Leukemia: A National Population-Based Cohort Study.
Biol Blood Marrow Transplant
; 24(2): 314-323, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29051022
14.
Autoimmune diseases, infections, use of antibiotics and the risk of acute myeloid leukaemia: a national population-based case-control study.
Br J Haematol
; 181(2): 205-214, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29504124
15.
Severity and 90-day survival of SARS-CoV-2 infection among patients with haematological disorders.
Acta Oncol
; 61(4): 500-504, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35038967
16.
Work Disability and Return to Work After Treatment for Acute Lymphoblastic Leukemia: A Danish Nationwide Cohort Study.
Clin Epidemiol
; 16: 191-202, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38500516
17.
Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia.
Leukemia
; 38(4): 712-719, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38287133
18.
Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3 Mutations.
J Clin Oncol
; 42(10): 1158-1168, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38215358
19.
Venetoclax-based low intensity therapy in molecular failure of NPM1-mutated AML.
Blood Adv
; 8(2): 343-352, 2024 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38039513
20.
Flow Sorting, Whole Genome Amplification and Next-Generation Sequencing as Combined Tools to Study Heterogeneous Acute Lymphoblastic Leukemia.
Diagnostics (Basel)
; 13(21)2023 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37958202